{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:41:27Z","timestamp":1789166487682,"version":"build-2803163510"},"reference-count":73,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"11","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Peripheral T-cell lymphomas (PTCLs) encompass a group of rare and diverse disease entities for which contemporary frontline treatment options are limited. Patient outcomes for PTCL remain poor globally, and disparities in health care resources and health care system variability across East and Southeast Asia (hereafter referred to as Asia) further complicate PTCL management in the region. This article reviews the practice landscape for PTCL in Asia, provides a nuanced perspective on the challenges faced by physicians in the region, and suggests how patient outcomes can be improved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>A panel of lymphoma experts from 10 countries\/territories across Asia convened at the Singapore Lymphoma Scientific Symposium 2024 to discuss local PTCL management practices. Discussions were supplemented by perspectives from an expert from the United States and a review of published literature on PTCL in Asia in the past 10 years. Meeting discussions and relevant aspects of Asian PTCL practice preferences are summarized in this article.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>In Asia, PTCL diagnosis and management are hindered by the lack of available domain experts, limitations in infrastructure support and funding, and substantial challenges in accessing novel drugs; relapsed\/refractory PTCL, in particular, remains an area of great clinical unmet need. To improve the standard of care for patients with PTCL, cross-country collaborative efforts will be required to facilitate cross-border knowledge sharing, enhance access to expertise and specialized pathology services, increase local clinical trial presence, and offer educational and research opportunities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Significant challenges remain for PTCL management in Asia. Concerted efforts to enhance diagnostic accuracy, improve access to innovative therapies, and establish robust international partnerships are crucial for achieving better outcomes for patients with PTCL in the region.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-25-00353","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:59:18Z","timestamp":1761163158000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":2,"title":["Peripheral T-Cell Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4801-3703","authenticated-orcid":true,"given":"Jason Yongsheng","family":"Chan","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore"},{"name":"Duke-NUS Medical School, National Cancer Centre Singapore, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5406-9300","authenticated-orcid":true,"given":"Ayumi","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan"},{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3381-5102","authenticated-orcid":true,"given":"Esther Wei Yin","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore"},{"name":"Duke-NUS Medical School, National Cancer Centre Singapore, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2129-782X","authenticated-orcid":true,"given":"Gin Gin","family":"Gan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen Mui","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Haematology, Ampang Hospital, Ampang Jaya, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3561-9761","authenticated-orcid":true,"given":"Soo Chin","family":"Ng","sequence":"additional","affiliation":[{"name":"Subang Jaya Medical Center, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0804-9389","authenticated-orcid":true,"given":"Kian Meng","family":"Chang","sequence":"additional","affiliation":[{"name":"Sunway Medical Centre, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Caguioa","sequence":"additional","affiliation":[{"name":"Section of Medical Oncology, St Luke's Medical Center, Quezon City, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8043-8234","authenticated-orcid":true,"given":"Jay","family":"Datukan","sequence":"additional","affiliation":[{"name":"Section of Medical Oncology, St Luke's Medical Center, Quezon City, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangming","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suporn","family":"Chuncharunee","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6830-7339","authenticated-orcid":true,"given":"Do Huyen","family":"Nga","sequence":"additional","affiliation":[{"name":"Department of Hematologic Oncology, Vietnam National Cancer Hospital, Hanoi, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1384-0749","authenticated-orcid":true,"given":"Noorwati","family":"Sutandyo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Dharmais National Cancer Center Hospital, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6402-4288","authenticated-orcid":true,"given":"Choon Kiat","family":"Ong","sequence":"additional","affiliation":[{"name":"Duke-NUS Medical School, National Cancer Centre Singapore, Singapore, Singapore"},{"name":"Lymphoma Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8854-9414","authenticated-orcid":true,"given":"Michelle Limei","family":"Poon","sequence":"additional","affiliation":[{"name":"Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9816-6137","authenticated-orcid":true,"given":"Anand","family":"Jeyasekharan","sequence":"additional","affiliation":[{"name":"Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagavalli","family":"Somasundaram","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore"},{"name":"Duke-NUS Medical School, National Cancer Centre Singapore, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-7612","authenticated-orcid":true,"given":"Matthew","family":"Lunning","sequence":"additional","affiliation":[{"name":"University of Nebraska, Omaha, NE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5974-7614","authenticated-orcid":true,"given":"Ritsuro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9129-8057","authenticated-orcid":true,"given":"Koji","family":"Izutsu","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8351-4722","authenticated-orcid":true,"given":"Eric","family":"Tse","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Hong Kong, Hong Kong Special Administrative Region, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0366-5505","authenticated-orcid":true,"given":"Soon Thye","family":"Lim","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore"},{"name":"Duke-NUS Medical School, National Cancer Centre Singapore, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5400-0466","authenticated-orcid":true,"given":"Won Seog","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102793"},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2"},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015851"},{"key":"e_1_3_8_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01560-7"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-014-1520-3"},{"key":"e_1_3_8_8_2","first-page":"100126","article-title":"Comprehensive analysis of peripheral T-cell and natural killer\/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia","volume":"10","author":"Yoon SE","year":"2021","unstructured":"Yoon SE, Song Y, Kim SJ, et al: Comprehensive analysis of peripheral T-cell and natural killer\/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia. Lancet Reg Health West Pac 10:100126, 2021","journal-title":"Lancet Reg Health West Pac"},{"key":"e_1_3_8_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304083281404"},{"key":"e_1_3_8_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13831"},{"key":"e_1_3_8_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2392"},{"key":"e_1_3_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.12.002"},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-270785"},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021015114"},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-573089"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017010819"},{"key":"e_1_3_8_17_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01815"},{"key":"e_1_3_8_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0838-5"},{"key":"e_1_3_8_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2021.1955344"},{"key":"e_1_3_8_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-821009"},{"key":"e_1_3_8_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.2456"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-584953"},{"key":"e_1_3_8_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.7069"},{"key":"e_1_3_8_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001821"},{"key":"e_1_3_8_25_2","doi-asserted-by":"publisher","DOI":"10.5402\/2011\/623924"},{"key":"e_1_3_8_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2014.34"},{"key":"e_1_3_8_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30416"},{"key":"e_1_3_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30039-5"},{"key":"e_1_3_8_29_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1230629"},{"key":"e_1_3_8_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-205353"},{"key":"e_1_3_8_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-024-02254-x"},{"key":"e_1_3_8_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003971"},{"key":"e_1_3_8_33_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.2719"},{"key":"e_1_3_8_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31861"},{"key":"e_1_3_8_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu443"},{"key":"e_1_3_8_36_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1300888"},{"key":"e_1_3_8_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx787"},{"key":"e_1_3_8_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-017-0030-y"},{"key":"e_1_3_8_39_2","unstructured":"National Library of Medicine: NCT05444712: Transplantation after complete response in patients with T-cell lymphoma (TRANSCRIPT)"},{"key":"e_1_3_8_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyae144"},{"key":"e_1_3_8_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05708-w"},{"key":"e_1_3_8_42_2","doi-asserted-by":"publisher","DOI":"10.47829\/COO.2024.71102"},{"key":"e_1_3_8_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18885"},{"key":"e_1_3_8_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2705"},{"key":"e_1_3_8_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25463"},{"key":"e_1_3_8_46_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002396"},{"key":"e_1_3_8_47_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.9024"},{"key":"e_1_3_8_48_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.4223"},{"key":"e_1_3_8_49_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0402"},{"key":"e_1_3_8_50_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.0924"},{"key":"e_1_3_8_51_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.2782"},{"key":"e_1_3_8_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv237"},{"key":"e_1_3_8_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3418-2"},{"key":"e_1_3_8_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14671"},{"key":"e_1_3_8_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25967"},{"key":"e_1_3_8_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14906"},{"key":"e_1_3_8_57_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008615"},{"key":"e_1_3_8_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00503-5"},{"key":"e_1_3_8_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00589-2"},{"key":"e_1_3_8_60_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-780049"},{"key":"e_1_3_8_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28676"},{"key":"e_1_3_8_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.10.001"},{"key":"e_1_3_8_63_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-692541"},{"key":"e_1_3_8_64_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"e_1_3_8_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00700-7"},{"key":"e_1_3_8_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12386"},{"key":"e_1_3_8_67_2","volume-title":"Patient Access to Innovative Cancer Drugs in Asia-Pacific","author":"Hofmarcher T","year":"2021","unstructured":"Hofmarcher T, Keel G, Lindgren P: Patient Access to Innovative Cancer Drugs in Asia-Pacific. IHE Report 2021:3e. Lund, Sweden, IHE, 2021"},{"key":"e_1_3_8_68_2","doi-asserted-by":"publisher","DOI":"10.1200\/GO.23.00040"},{"key":"e_1_3_8_69_2","first-page":"3b","volume-title":"Cancer Care and Access to Cancer Drugs in Asia-Pacific","author":"Hofmarcher T","year":"2021","unstructured":"Hofmarcher T, Keel G, Lindgren P: Cancer Care and Access to Cancer Drugs in Asia-Pacific. IHE Report 2021. Lund, Sweden, IHE, 2021. p 3b"},{"key":"e_1_3_8_70_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2023.07.004"},{"key":"e_1_3_8_71_2","doi-asserted-by":"publisher","DOI":"10.56506\/VUWA5043"},{"key":"e_1_3_8_72_2","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2013.14.4.2159"},{"key":"e_1_3_8_73_2","first-page":"101160","article-title":"Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): An open-label, multicentre phase 2 clinical trial","volume":"50","author":"Cai MC","year":"2024","unstructured":"Cai MC, Cheng S, Jing HM, et al: Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): An open-label, multicentre phase 2 clinical trial. Lancet Reg Health West Pac 50:101160, 2024","journal-title":"Lancet Reg Health West Pac"},{"key":"e_1_3_8_74_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009767"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-25-00353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:59:29Z","timestamp":1761163169000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-25-00353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":73,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1200\/GO-25-00353"],"URL":"https:\/\/doi.org\/10.1200\/go-25-00353","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-06-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500353"}}